- Home
- ORGO vs PHLT Comparison
ORGO vs PHLT Comparison
Compare ORGO & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- PHLT
- Stock Information
- Founded
- ORGO 1985
- PHLT 1976
- Country
- ORGO United States
- PHLT United States
- Employees
- ORGO N/A
- PHLT N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- PHLT Other Consumer Services
- Sector
- ORGO Health Care
- PHLT Consumer Discretionary
- Exchange
- ORGO Nasdaq
- PHLT Nasdaq
- Market Cap
- ORGO 620.3M
- PHLT 601.2M
- IPO Year
- ORGO N/A
- PHLT N/A
- Fundamental
- Price
- ORGO $4.92
- PHLT $7.70
- Analyst Decision
- ORGO Buy
- PHLT Buy
- Analyst Count
- ORGO 2
- PHLT 2
- Target Price
- ORGO $7.50
- PHLT $7.88
- AVG Volume (30 Days)
- ORGO 729.3K
- PHLT 1.6M
- Earning Date
- ORGO 11-11-2025
- PHLT 11-05-2025
- Dividend Yield
- ORGO N/A
- PHLT N/A
- EPS Growth
- ORGO N/A
- PHLT N/A
- EPS
- ORGO N/A
- PHLT N/A
- Revenue
- ORGO $429,531,000.00
- PHLT $137,357,000.00
- Revenue This Year
- ORGO $2.57
- PHLT $12.38
- Revenue Next Year
- ORGO $9.80
- PHLT $10.09
- P/E Ratio
- ORGO N/A
- PHLT N/A
- Revenue Growth
- ORGO N/A
- PHLT 15.21
- 52 Week Low
- ORGO $2.48
- PHLT $2.17
- 52 Week High
- ORGO $6.71
- PHLT $7.74
- Technical
- Relative Strength Index (RSI)
- ORGO 54.02
- PHLT 82.79
- Support Level
- ORGO $4.75
- PHLT $7.56
- Resistance Level
- ORGO $5.10
- PHLT $7.67
- Average True Range (ATR)
- ORGO 0.21
- PHLT 0.03
- MACD
- ORGO -0.01
- PHLT -0.11
- Stochastic Oscillator
- ORGO 51.40
- PHLT 95.83
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.